Patents by Inventor Chris Dong

Chris Dong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11793419
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Grant
    Filed: November 14, 2022
    Date of Patent: October 24, 2023
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Jeremy Frank, Nikhil Pargaonkar, Raymond Schmidt, Robert Azevedo, Kurt Scheinpflug, Nikolaus Leist, Chris Dong, Hiren Patel, Peter Bjeletich, Robert Duck
  • Patent number: 11684605
    Abstract: Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: June 27, 2023
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kurt Scheinpflug, Nikhil Pargaonkar, Chris Dong, Ai Ling Ching, Dawn Adkin
  • Publication number: 20230076111
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Application
    Filed: November 14, 2022
    Publication date: March 9, 2023
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Jeremy FRANK, Nikhil PARGAONKAR, Raymond SCHMIDT, Robert AZEVEDO, Kurt SCHEINPFLUG, Nikolaus LEIST, Chris DONG, Hiren PATEL, Peter BJELETICH, Robert DUCK
  • Patent number: 11529071
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: December 20, 2022
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Jeremy Frank, Nikhil Pargaonkar, Raymond Schmidt, Robert Azevedo, Kurt Scheinpflug, Nikolaus Leist, Chris Dong, Hiren Patel, Peter Bjeletich, Robert Duck
  • Publication number: 20220079919
    Abstract: Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
    Type: Application
    Filed: October 6, 2021
    Publication date: March 17, 2022
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Kurt Scheinpflug, Nikhil Pargaonkar, Chris Dong, Ai Ling Ching, Dawn Adkin
  • Patent number: 11166939
    Abstract: Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: November 9, 2021
    Assignee: OTSUKA PHARMACEUTICAL CO. LTD
    Inventors: Kurt Scheinpflug, Nikhil Pargaonkar, Chris Dong, Ai Ling Ching, Dawn Adkin
  • Publication number: 20210212592
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Application
    Filed: September 28, 2020
    Publication date: July 15, 2021
    Applicant: Otsuka America Pharmaceutical, Inc.
    Inventors: Jeremy FRANK, Nikhil PARGAONKAR, Raymond SCHMIDT, Robert AZEVEDO, Kurt SCHEINPFLUG, Nikolaus LEIST, Chris DONG, Hiren PATEL, Peter BJELETICH, Robert DUCK
  • Patent number: 10820831
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: November 3, 2020
    Inventors: Jeremy Frank, Nikhil Pargaonkar, Raymond Schmidt, Robert Azevedo, Kurt Scheinpflug, Nikolaus Leist, Chris Dong, Hiren Patel, Peter Bjeletich, Robert Duck
  • Publication number: 20190216776
    Abstract: Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
    Type: Application
    Filed: April 25, 2018
    Publication date: July 18, 2019
    Inventors: Kurt Scheinpflug, Nikhil Pargaonkar, Chris Dong, Ai Ling Ching, Dawn Adkin
  • Publication number: 20180110441
    Abstract: Various methods and apparatuses are presented for an ingestible capsule that includes a digital, ingestible sensor component—or ingestible sensor—embedded into the capsule. The ingestible sensor component may be configured to activate upon coming into contact with conductive fluid, such as a body's stomach fluid. Once activated, the ingestible sensor component may be configured to perform various tasks, such as transmitting one or more signals and obtaining biometric data about the body that ingested the capsule.
    Type: Application
    Filed: October 26, 2017
    Publication date: April 26, 2018
    Inventors: Jeremy Frank, Nikhil Pargaonkar, Raymond Schmidt, Robert Azevedo, Kurt Scheinpflug, Nikolaus Leist, Chris Dong, Hiren Patel, Peter Bjeletich
  • Patent number: 6861015
    Abstract: A method of integrally forming light-guide board and polarizer. A polarizer and a mold with a first space and a second space are provided. The polarizer is fixed in the first space. A light-guide material is injected into the second space. By curing the light-guide material, a light-guide board is formed, and the polarizer and the light-guide are integrated together.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: March 1, 2005
    Assignee: Au Optronics Corporation
    Inventors: Chris Dong, Kelly Wei
  • Publication number: 20040189588
    Abstract: A back light module for providing a full-color surface light source. The back light module comprises a surface light source, a light-shielding matrix and a fluorescent layer. The light-shielding matrix is formed on the surface of the surface light source. The light-shielding layer has a plurality of lattice points that exposes the surface of the surface light source. The fluorescent layer is formed inside the lattice points. Through the fluorescent layer, light emitted from the surface light source is able to produce full coloration. A liquid crystal display comprises the back light module and a liquid crystal display panel. The liquid crystal display panel comprises an array substrate, an opposite substrate and a liquid crystal layer. The opposite substrate is positioned over the array substrate and the liquid crystal layer is sandwiched between the array substrate and the opposite substrate. The liquid crystal display panel is set up over the back light module.
    Type: Application
    Filed: January 8, 2004
    Publication date: September 30, 2004
    Inventors: CHRIS DONG, CHE-CHIH CHANG
  • Publication number: 20030016314
    Abstract: A method of integrally forming light-guide board and polarizer. A polarizer and a mold with a first space and a second space are provided. The polarizer is fixed in the first space. A light-guide material is injected into the second space. By curing the light-guide material, a light-guide board is formed, and the polarizer and the light-guide are integrated together.
    Type: Application
    Filed: May 23, 2002
    Publication date: January 23, 2003
    Inventors: Chris Dong, Kelly Wei